Trial Profile
A multicenter, retrospective study to compare the perioperative and renal functional outcomes of renal cell cancer patients with or without pre-surgical sunitinib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cancer
- Focus Adverse reactions
- 19 Aug 2015 New trial record